Breaking NewsCovid-19

New Facility Center to Monoclonal Antibody Treatment at Main Street Library Location

After getting COVID positive reports, Texas Gov. Greg Abbott is going through this treatment, stated by his communications director. 

A new facility to provide monoclonal antibody treatment for people infected with coronavirus opened at the Jacksonville Main Library Conference Center on 17th Aug. Patients at risk can receive treatment without prescription or referral, as per the order from Gov. Ron DeSantis. 

Who can receive it?

The lab-manufactured monoclonal antibody treatment promises for those infected with coronavirus when used within ten days of symptoms onset. The treatment can be a lifesaver for COVID-19 patients, who are mainly at risk for severe illness. People can run the facility to prevent themselves from going to the hospital. According to the FDA, the treatment could limit virus-related hospitalizations or emergency room comings.

After getting COVID positive reports, Texas Gov. Greg Abbott is going through this treatment, stated by his communications director. 

The treatment at the facility is available for those 12+ years, recommended to patients tested positive for the virus or within ten days of developing symptoms. People visiting for treatment should be at high risk for critical illness, hospitalization, or death due to infection.

The center will serve patients from Monday to Friday between 9 AM. – 5 PM. 

How do monoclonal antibody treatments work?

A coronavirus infected patient’s body takes time to generate the required antibodies to strike the infection. It includes a mix of two antibodies that support the patient’s body to check the virus from being drug-resistant. These monoclonal antibodies are infused into the patient’s body to help them in the faster immune response.

The chief investigator of novel virus clinical trials at Baylor Scott & White, Dr. Robert Gottlieb, testing the Eli Lilly and Regeneron formulations, said that the monoclonal antibodies have already been used to treat autoimmune diseases. Patients tolerated it well. 

The virus replicates most actively in the early days of infection. Therefore, scientists believe patients should receive antibody treatment as soon as possible after symptoms onset. 

Show More

Harish Yadav

Finance and market analyst and chief writer on howtofinance. Passionate to read books and articles on marketing and accounting. Also edits other articles and publish them here.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker